Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login

  Download for Citation Managers



ORIGINAL ARTICLE

Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil-cetuximab in first-line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy, which is standard?
Mutlu Hasan, Salim Derya Kıvrak, Gündüz Şeyda, Eryılmaz Melek Karakurt, Musri Fatma Yalçın, Coşkun Hasan Şenol

Year : 2017 | Volume:  13 | Issue Number:  3 | Page: 510-513



Click here to read this article


Select type of program  for download
EndNote
EndNote format (Mac & Win)
- Download
Reference Manager
Ris format (Win only)
- Download
Procite
Ris format (Win only)
- Download
Medlars Format - Download
RefWorks Format
RefWorks format (Mac & Win)
- Download
BibTex Format
BibTex format (Mac & Win)
- Download
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal